Lonza Clonetics HSeC-Human Sertoli cells

Monday, 11 October, 2010 | Supplied by: Capsugel Australia Pty Ltd

Lonza Clonetics HSeC-Human Sertoli cells

Clonetics HSeC-Human Sertoli Cells are an asset to research involving male infertility and reproductive toxicology, xeno/allograft cotransplantation, immune suppression and many other applications.

Sertoli cells are highly specialised and essential for maintenance of testicular homeostasis and male reproductive viability.

QC characterisation of Sertoli cells includes testing for cellular proteins, seeding efficiency, doubling time and morphology and 70% confluence by day 12 in culture. Cells test positive for GATA-4 and Sox-9 at > 70% by flow cytometry.

Cells test negative for mycoplasma, bacteria, yeast and fungi. HIV-1 and Hepatitis B/C are not detected for all donors and/or cell lots.

A Certificate of Analysis is provided for each cell lot purchased.

Clonetics cells are guaranteed to perform as indicated when used with Clonetics Media and Reagents

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Biosensis MAP2 antibodies

Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...

Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration

The antibodies are specific to CTC surface markers to enable the sensitive and specific...

Microbiologics UV-BioTAG QC microorganisms for quality control testing

UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd